Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
about
Postural instability in patients with Parkinson's disease. Epidemiology, pathophysiology and management.Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.New treatments for the motor symptoms of Parkinson's disease.Intravenous amantadine for freezing of gait resistant to dopaminergic therapy: a randomized, double-blind, placebo-controlled, cross-over clinical trial.Monoamine reuptake inhibitors in Parkinson's disease.Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property space.Efficacy of exercise intervention programs on cognition in people suffering from multiple sclerosis, stroke and Parkinson's disease: A systematic review and meta-analysis of current evidence.The Effects of Methylphenidate on Resting-State Functional Connectivity of the Basal Nucleus of Meynert, Locus Coeruleus, and Ventral Tegmental Area in Healthy Adults.Freezing of Gait in Parkinsonism and its Potential Drug Treatment.Treatment of Parkinson's disease: what's in the non-dopaminergic pipeline?Normal and pathological gait: what we learn from Parkinson's disease.Drug treatments for the neuropsychiatric complications of Parkinson's disease.Freezing of gait in Parkinson's disease: where are we now?Non-dopaminergic treatments for motor control in Parkinson's disease.Clinical syndromes: Parkinsonian gait.What are the priorities in Parkinson's disease clinical research? A focus on motor complications, gait and cognition.Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement.Nondopaminergic treatments for Parkinson's disease: current and future prospects.Pharmacological treatment in Parkinson's disease: Effects on gait.Freezing of gait in Parkinson's disease: from pathophysiology to emerging therapies.Gait function and locus coeruleus Lewy body pathology in 51 Parkinson's disease patients.Advances in Therapeutic Options for Gait and Balance in Parkinson's DiseaseMethylphenidate : a treatment for Parkinson's disease?ExPPNing how acetylcholine improves gait in Parkinson's disease: An Editorial Highlight for 'Deletion of the Vesicular Acetylcholine Transporter from Pedunculopontine/laterodorsal tegmental neurons modifies gait'.Motor Complications of Dopaminergic Medications in Parkinson's Disease.
P2860
Q34306751-E220B406-525E-48DA-B8BF-A9AA57F937E6Q34388686-C31A4C84-DEF0-4A70-B376-2202958E72B9Q34443682-281DB044-BDE0-4FBF-A7D5-A63E6053F716Q34489770-4419DECC-15D8-4E6E-9E8C-B5459B707B4BQ35165280-9C724D3C-9F7E-4D9C-AF88-6D4108894A27Q35614156-451CC26E-BA88-4265-B12B-2E1A4415EAE4Q35625767-8F9C144D-3C4D-45CE-B076-0571A2D0EFB3Q35814149-80CB99E1-57AB-44EA-9250-1B4AD8535CB3Q36805793-159CEFE8-297F-4768-8EAD-80748CA136A3Q36925884-C7390F8F-820C-4FDD-90F5-511979799F3CQ37506507-B35B7133-A37F-43AD-97B1-DDC502939A0CQ38023268-D40CF58B-19F6-4A72-9940-958C1BC04889Q38067142-7C087620-6ED0-461D-AED8-86554F2E6DB8Q38102609-8B79D70F-98B6-4353-B0CF-F06141C42B52Q38126817-86D6BD7A-9530-4FE4-AC23-A551EE858EA4Q38153328-B22799DB-CA37-4DBB-A631-15F0EDD0CA99Q38212033-A05B6FE2-9E14-42EF-8609-FFBBB2A70BBEQ38258228-A1DD4E82-6AE0-45CB-A70D-DDEA02CEC62FQ38845546-282649F7-7E8E-4802-8BD0-570ABEBA36DCQ38909702-55201FE0-DE02-4BEF-AC16-9C32F3FE5EBBQ38947418-D35FD1CB-179A-4403-B479-C30EC4F69A0FQ39332170-1715AAE3-A5CA-43EB-A1DE-39EAB24FFB5BQ39692778-614E32C0-D920-457A-A53B-D89B51906FD6Q48290666-640A04F5-9F36-4ADA-BE8B-4FA25F158F0BQ48370307-2682D9FF-74DD-4BB2-AC10-3E31A8DC7221Q55279095-48DEEBB8-E94A-44CA-8811-A380FF5037E2
P2860
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
@ast
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
@en
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
@nl
type
label
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
@ast
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
@en
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
@nl
prefLabel
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
@ast
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
@en
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
@nl
P2093
P2860
P1433
P1476
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
@en
P2093
A K Dwivedi
B N Maddux
F J Revilla
J E Vaughan
J T Slevin
P2860
P304
P356
10.1212/WNL.0B013E3182143537
P407
P577
2011-04-01T00:00:00Z